Company Directory > CDMO > Acme Generics
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Acme Generics and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Acme Generics is a leading pharmaceutical contract development and manufacturing organization (CDMO) based in Northern India. Founded in 2005, the company provides fully integrated manufacturing and development solutions, specializing in oral solid dosage forms (tablets/capsules), hormones (including female sex hormones and levothyroxine), and sterile injectables (liquid and lyophilized). The company operates as part of the broader Acme Group, which includes Acme Formulation, Immacule Lifesciences, and Veritas Research. With over 1 million square feet of manufacturing space and a workforce of over 2,500, Acme serves top Indian and global pharmaceutical companies, maintaining compliance with major international regulatory bodies including the USFDA, UK-MHRA, EU-GMP, Health Canada, and TGA Australia.
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:
Industry:CDMO
Sub-Industry:Pharmaceutical Contract Manufacturing
SIZE & FINANCIALS
Employees:1001-5000
Founded:2005
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Oral solid dosage, Sterile injectables
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Acme Formulation, Immacule Lifesciences, Veritas Research
Key Partnerships:Top Indian and global pharmaceutical companies (clients)
COMPETITION
Position:Leader
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Acme Generics. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.